Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 12/20 | 0.75 |
| ▸ | HIF1A | Q16665 | 9/20 | 0.75 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.75 |
| ▸ | PGR | P06401 | 2/20 | 0.75 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.75 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.75 |
| ▸ | SHBG | P04278 | 1/20 | 0.75 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.75 |
| ▸ | MAPT | P10636 | 1/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.75 |
| ▸ | LMNA | P02545 | 2/20 | 0.70 |
| ▸ | AR | P10275 | 1/20 | 0.70 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.70 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tixocortol Pivalate SCHEMBL5484132 | 1.00 | NR3C1 (0.75) | NR3C1HIF1ACYP2C19HSD17B10PGR | |
| Tixocortol Pivalate SCHEMBL6827 | 1.00 | NR3C1 (0.75) | NR3C1HIF1ACYP2C19HSD17B10PGR | |
| Tixocortol Pivalate SCHEMBL1792227 | 0.95 | HIF1A (0.69) | NR3C1HIF1ACYP2C19HSD17B10PGR | |
| Tixocortol Pivalate SCHEMBL16516121 | 0.90 | NR3C1 (0.72) | NR3C1HIF1ACYP2C19HSD17B10PGR | |
| SCHEMBL903442 | 0.87 | HIF1A (0.59) | NR3C1HIF1ACYP2C19HSD17B10PGR | |
| Hydrocortisone SCHEMBL27426095 | 0.87 | HIF1A (0.89) | NR3C1HIF1ACYP2C19HSD17B10PGR | |
| Hydrocortisone SCHEMBL24900238 | 0.86 | HIF1A (1.00) | NR3C1HIF1ACYP2C19HSD17B10PGR | |
| SCHEMBL12396665 | 0.86 | HIF1A (0.85) | NR3C1HIF1ACYP2C19HSD17B10PGR | |
| Hydrocortisone SCHEMBL13046615 | 0.86 | HIF1A (1.00) | NR3C1HIF1ACYP2C19HSD17B10PGR | |
| Hydrocortisone SCHEMBL15114813 | 0.86 | HIF1A (1.00) | NR3C1HIF1ACYP2C19HSD17B10PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5688 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4301343-B1 | PHARMACEUTICAL COMPOSITIONS WITH REDUCED SIDE EFFECT AND METHODS OF USING THE SAME | TLC BIOPHARMACEUTICALS INC (US) | 2025-11-19 | — | — | EP | claimed |
| EP-4178579-B1 | 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE AS GLUCOCORTICOID-SPARING AGENT | METRIOPHARM AG (CH) | 2025-02-12 | — | — | EP | claimed |
| EP-4495261-A1 | DETECTION OF CORTICOSTEROID EFFICIENCY BY ANALYSING THE RS37973 AND RS28362491 POLYMORPHISMS | Université de Versailles Saint-Quentin-en-Yvelines (FR) | 2025-01-22 | — | — | EP | claimed |
| EP-4475851-A1 | FORMULATIONS FOR TRANSDERMAL ADMINISTRATION OF ACTIVE AGENTS | Dyve Biosciences, Inc. (US) | 2024-12-18 | — | — | EP | claimed |
| US-20240390265-A1 | FORMULATIONS FOR TRANSDERMAL ADMINISTRATION OF ACTIVE AGENTS | DYVE BIOSCIENCES, INC. | 2024-11-28 | — | — | US | claimed |
| EP-3773563-B1 | PRODRUGS OF FUSED-BICYCLIC C5AR ANTAGONISTS | CHEMOCENTRYX INC (US) | 2024-10-16 | — | — | EP | claimed |
| EP-4433091-A1 | PROCESS AND THERAPEUTIC COMPOSITION FOR TREATING AND PREVENTING SEVERE INJECTION SITE REACTIONS | Brii Biosciences, Inc. (US) | 2024-09-25 | — | — | EP | claimed |
| US-20240156839-A1 | PHARMACEUTICAL COMPOSITIONS WITH REDUCED SIDE EFFECT AND METHODS OF USING THE SAME | TLC BIOPHARMACEUTICALS, INC. | 2024-05-16 | — | — | US | claimed |
| EP-3728203-B1 | DIARYL SUBSTITUTED 6,5-FUSED RING COMPOUNDS AS C5aR INHIBITORS | CHEMOCENTRYX INC (US) | 2024-03-13 | — | — | EP | claimed |
| WO-2001015744-A1 | SYSTEMIC INFLAMMATORY MARKERS AS DIAGNOSTIC TOOLS IN THE PREVENTION OF ATHEROSCLEROTIC DISEASES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2001-03-08 | — | — | WO | claimed |
| EP-1003501-A4 | MEANS OF ASCERTAINING AN INDIVIDUAL'S RISK PROFILE FOR ATHEROSCLEROTIC DISEASE | BRIGHAM & WOMENS HOSPITAL (US) | 2001-01-17 | — | — | EP | claimed |
| EP-1003501-A1 | MEANS OF ASCERTAINING AN INDIVIDUAL'S RISK PROFILE FOR ATHEROSCLEROTIC DISEASE | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2000-05-31 | — | — | EP | claimed |
| WO-2000028974-A1 | LOCAL DELIVERY OF DRUGS TO THE COLON FOR LOCAL TREATMENT OF COLONIC DISEASES | DEXXON LTD. (IL) | 2000-05-25 | — | — | WO | claimed |
| US-5849327-A | Delivery of drugs to the lower gastrointestinal tract | ADVANCED POLYMER SYSTEMS, INC. (US) | 1998-12-15 | — | — | US | claimed |
| EP-0876142-A1 | TOPICAL DELIVERY OF DRUGS TO THE LOWER GASTROINTESTINAL TRACT | Advanced Polymer Systems, Inc. (US) | 1998-11-11 | — | — | EP | claimed |
| WO-1998043630-A1 | MEANS OF ASCERTAINING AN INDIVIDUAL'S RISK PROFILE FOR ATHEROSCLEROTIC DISEASE | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 1998-10-08 | — | — | WO | claimed |
| US-5681584-A | SOLID CORE OF ACTIVE AGENT, SOLUBLE DELAY JACKET COATING, SEMIPERMEABLE MEMBRANE, AND ADDITIONAL LAYER OF ACTIVE AGENT | CIBA-GEIGY CORPORATION (US) | 1997-10-28 | — | — | US | claimed |
| WO-1997027843-A2 | TARGETED DELIVERY OF DRUGS TO THE LOWER GASTROINTESTINAL TRACT | ADVANCED POLYMER SYSTEMS, INC. (US) | 1997-08-07 | — | — | WO | claimed |
| WO-1997025980-A1 | TOPICAL DELIVERY OF DRUGS TO THE LOWER GASTROINTESTINAL TRACT | ADVANCED POLYMER SYSTEMS, INC. (US) | 1997-07-24 | — | — | WO | claimed |